津普森 |
B305233-10mg |
10mg |
现货 |
366017-09-6 |
(E)-4-((4-(4-(1H-1,2,3-三唑-1-... |
98%,B |
302.20
302.20
|
|
津普森 |
B305233-5mg |
5mg |
现货 |
366017-09-6 |
(E)-4-((4-(4-(1H-1,2,3-三唑-1-... |
98%,B |
178.00
178.00
|
|
罗恩 |
R024143-10mg |
10mg |
5~7个工作日 |
366017-09-6 |
Mubritinib (TAK 165) Mubritinib (TAK 165) |
99% |
499.00
499.00
|
|
罗恩 |
R024143-250mg |
250mg |
5~7个工作日 |
366017-09-6 |
Mubritinib (TAK 165) Mubritinib (TAK 165) |
99% |
7,416.00
7,416.00
|
|
罗恩 |
R024143-50mg |
50mg |
5~7个工作日 |
366017-09-6 |
Mubritinib (TAK 165) Mubritinib (TAK 165) |
99% |
1,759.00
1,759.00
|
|
Selleck |
S221610mg |
10mg |
现货 |
366017-09-6 |
Mubritinib (TAK 165) |
|
581.24
581.24
|
|
Selleck |
S2216200mg |
200mg |
现货 |
366017-09-6 |
Mubritinib (TAK 165) |
|
7,127.59
7,127.59
|
|
Selleck |
S221625mg |
25mg |
现货 |
366017-09-6 |
Mubritinib (TAK 165) |
|
1,218.18
1,218.18
|
|
毕得 |
BD140529-10mg |
10mg |
现货 |
366017-09-6 |
(E)-4-((4-(4-(1H-1,2,3-三唑-1-... (E)-4-((4-(4-(1H-1,2,3-Triaz... |
98% |
438.00
438.00
|
|
毕得 |
BD140529-5mg |
5mg |
现货 |
366017-09-6 |
(E)-4-((4-(4-(1H-1,2,3-三唑-1-... (E)-4-((4-(4-(1H-1,2,3-Triaz... |
98% |
258.00
258.00
|
|
阿拉丁 |
M129797-10mg |
10mg |
现货 |
366017-09-6 |
木利替尼 Mubritinib (TAK 165) |
Moligand™, ≥99% |
415.90
415.90
|
|
阿拉丁 |
M129797-50mg |
50mg |
现货 |
366017-09-6 |
木利替尼 Mubritinib (TAK 165) |
Moligand™, ≥99% |
1,465.90
1,465.90
|
|
阿拉丁 |
M129797-250mg |
250mg |
期货,请咨询 |
366017-09-6 |
木利替尼 Mubritinib (TAK 165) |
Moligand™, ≥99% |
6,179.90
6,179.90
|
|
阿拉丁 |
M409057-1ml |
1ml |
现货 |
366017-09-6 |
木利替尼 Mubritinib (TAK 165) |
Moligand™, 10mM in DMSO |
308.90
308.90
|
|
梯希爱 |
M3058-25MG |
25MG |
现货 |
366017-09-6 |
木利替尼 Mubritini |
98.0% |
550.00
550.00
|
|
梯希爱 |
M3058-100MG |
100MG |
现货 |
366017-09-6 |
木利替尼 Mubritini |
98.0% |
2,055.00
2,055.00
|
|